Search research articles
Contact Us
Filters
Showing results (501-510 of 605) with videos related to
Page
of 61
Sort By:
Cancer
|
September 17, 2014
Parent decision-making around the genetic testing of children for germline TP53 mutations
Melissa A Alderfer, Kristin Zelley, Robert B Lindell, et al.
Science Advances
|
October 24, 2025
Biosensor-driven strain engineering reveals key cellular processes for maximizing isoprenol production in <i>Pseudomonas putida</i>
Javier Menasalvas, Shawn Kulakowski, Yan Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group
Timothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Clinical Breast Cancer
|
February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers
Tara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.
Contemporary Clinical Trials
|
September 18, 2024
Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control
Carol J Fabian, Dinesh Pal Mudaranthakam, Byron Gajewski, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 1, 2023
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ
Anne E O'Shea, Guy T Clifton, Na Qiao, et al.
Cell Reports
|
March 31, 2021
Trans-ethnic variation in germline variants of patients with renal cell carcinoma
Sarah Abou Alaiwi, Amin H Nassar, Elio Adib, et al.
Journal of the National Cancer Institute
|
May 30, 1998
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes
J S Brunet, P Ghadirian, T R Rebbeck, et al.
Cancer Research
|
April 5, 2017
Precancer Atlas to Drive Precision Prevention Trials
Avrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
Breast Cancer Research and Treatment
|
March 24, 2010
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis
Patricia G Moorman, Edwin S Iversen, P Kelly Marcom, et al.
Page
of 61
Search research articles
Search
Showing results (501-510 of 605) with videos related to
Sort By:
Page
of 61
Cancer
|
September 17, 2014
Parent decision-making around the genetic testing of children for germline TP53 mutations
Melissa A Alderfer, Kristin Zelley, Robert B Lindell, et al.
Science Advances
|
October 24, 2025
Biosensor-driven strain engineering reveals key cellular processes for maximizing isoprenol production in <i>Pseudomonas putida</i>
Javier Menasalvas, Shawn Kulakowski, Yan Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group
Timothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Clinical Breast Cancer
|
February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers
Tara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.
Contemporary Clinical Trials
|
September 18, 2024
Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control
Carol J Fabian, Dinesh Pal Mudaranthakam, Byron Gajewski, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 1, 2023
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ
Anne E O'Shea, Guy T Clifton, Na Qiao, et al.
Cell Reports
|
March 31, 2021
Trans-ethnic variation in germline variants of patients with renal cell carcinoma
Sarah Abou Alaiwi, Amin H Nassar, Elio Adib, et al.
Journal of the National Cancer Institute
|
May 30, 1998
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes
J S Brunet, P Ghadirian, T R Rebbeck, et al.
Cancer Research
|
April 5, 2017
Precancer Atlas to Drive Precision Prevention Trials
Avrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
Breast Cancer Research and Treatment
|
March 24, 2010
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis
Patricia G Moorman, Edwin S Iversen, P Kelly Marcom, et al.
Page
of 61